Top House Antitrust Lawmakers Held Meeting with Facebook Whistleblower

David Cicilline and Ken Buck

Top lawmakers in the House Judiciary antitrust subcommittee met with Facebook whistleblower Frances Haugen on Thursday, a person familiar with the matter confirmed to the Daily Caller News Foundation.

Democratic Rep. David Cicilline, who chairs the subcommittee, and Republican Rep. Ken Buck, who serves as ranking member, held a meeting with Haugen to discuss Facebook and issues related to social media competition, Politico first reported, citing two sources. A person familiar with the matter confirmed the meeting to the DCNF, and said the lawmakers also discussed potential antitrust reforms, as well as matters related to privacy and social media algorithms.

Buck and Cicilline worked together to advance a series of antitrust bills targeting major tech companies out of the House Judiciary Committee in June, and have both advocated for breaking up Facebook and other large platforms. The antitrust bills are currently set to reach the House floor in November.

Read More

Facebook Whistleblower Says Company ‘Paying for Its Profits with Our Safety’

Facebook knowingly chooses to prioritize its profits over the safety of its users, Frances Haugen, a whistleblower and former Facebook employee, said in an interview with “60 Minutes” on Sunday.

“The thing I saw at Facebook over and over again was there were conflicts of interest between what was good for the public and what was good for Facebook,” Haugen told Scott Pelley on “60 Minutes” Sunday night. “And Facebook, over and over again, chose to optimize for its own interests, like making more money.”

Haugen, a former Facebook product manager, leaked thousands of internal company documents to The Wall Street Journal last month which detail the inner workings of the company. The leaked documents showed that Facebook employs a separate content review system for high-profile accounts, the company has conducted research into the harms its Instagram platform has on teen users, and it stokes controversy by boosting inflammatory content.

Read More